Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124967) titled 'Clinical Study of 68Ga-NOTA-A9 PET Imaging for Evaluating CD276 Expression in Malignant Tumors' on May 19.
Study Type: Diagnostic test
Study Design:
Cross-sectional
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Lung cancer and esophageal cancer
Intervention:
Gold Standard:Tumor Histopathology
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-20
Target Sample Size: Target condition:8;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=320477
Published by HT Digital Content Services wit...